Deltex Medical Group (LSE:DEMG) COGS-to-Revenue : 0.45 (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Deltex Medical Group COGS-to-Revenue?

Deltex Medical Group's Cost of Goods Sold for the six months ended in Dec. 2023 was £0.32 Mil. Its Revenue for the six months ended in Dec. 2023 was £0.72 Mil.

Deltex Medical Group's COGS to Revenue for the six months ended in Dec. 2023 was 0.45.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Deltex Medical Group's Gross Margin % for the six months ended in Dec. 2023 was 55.37%.

Deltex Medical Group COGS-to-Revenue Historical Data

The historical data trend for Deltex Medical Group's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deltex Medical Group COGS-to-Revenue Chart

Deltex Medical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.23

0.32

0.30

0.26

0.37

Deltex Medical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.26	0.26	0.25	0.31	0.45

Deltex Medical Group COGS-to-Revenue Calculation

Deltex Medical Group's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.651	/	1.776
	=	0.37

Deltex Medical Group's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.32	/	0.717
	=	0.45

Deltex Medical Group (LSE:DEMG) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Deltex Medical Group's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.32 / 0.717
	=	55.37 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Deltex Medical Group COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Deltex Medical Group's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Deltex Medical Group (LSE:DEMG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltex Medical Group PLC (LSE:DEMG) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

DTXMF:USA

Address

Terminus Road, Chichester, W Sussex, GBR, PO19 8TX

Website

https://www.deltexmedical.com/

Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. It has developed the gold standard for haemodynamic monitoring with its oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring. This technology generates accurate, real-time data on descending aortic blood flow velocity in anesthetised or sedated patients.

Deltex Medical Group (LSE:DEMG) Headlines

No Headlines